Patent details

EP2797601 Title: PHARMACEUTICAL COMPOSITIONS TO REDUCE COMPLICATIONS OF OCULAR STEROID

Basic Information

Publication number:
EP2797601
PCT Application Number:
US2013025390
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP137470217
PCT Publication Number:
WO2013119988
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITIONS TO REDUCE COMPLICATIONS OF OCULAR STEROID
French Title of Invention:
COMPOSITIONS PHARMACEUTIQUES DESTINÉES À RÉDUIRE LES COMPLICATIONS LIÉES À UN STÉROÏDE OCULAIRE
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR VERMINDERUNG VON KOMPLIKATIONEN VON OKULAREM STEROID
SPC Number:

Dates

Filing date:
08/02/2013
Grant date:
21/03/2018
EP Publication Date:
05/11/2014
PCT Publication Date:
15/08/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/03/2018
EP B1 Publication Date:
21/03/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
08/02/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/03/2018
 
 

Name:
TLC Biopharmaceuticals, Inc.
Address:
432 North Canal Street 20, South San Francisco, CA 94080, United States (US)

Name:
Taiwan Liposome Company, Ltd.
Address:
11F-1 No 3 Yuanqu Street Nangang District, Taipei City, Taiwan (TW)

Agent

Name:
REGIMBEAU
From:
22/06/2018
Address:
RUE DE CHAZELLES 20, 75847, PARIS CEDEX 17, France (FR)
To:

Inventor

1

Name:
HONG, Keelung
Address:
United States (US)

2

Name:
LIN, Hong-Hui
Address:
Taiwan (TW)

3

Name:
TSENG, Yun-Long
Address:
Taiwan (TW)

4

Name:
GUO, Luke S.S.
Address:
United States (US)

5

Name:
SHIH, Sheue-Fang
Address:
Taiwan (TW)

6

Name:
TSAI, Chih-Chiang
Address:
Taiwan (TW)

7

Name:
CHANG, Po-Chun
Address:
Taiwan (TW)

Priority

Priority Number:
201261597189 P
Priority Date:
10/02/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/08; A61K 31/56; A61K 31/661; A61K 31/685; A61P 27/02;

Publication

European Patent Bulletin

Issue number:
201812
Publication date:
21/03/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/01/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
22/06/2018 Power Of Attorney 5